Literature DB >> 1988694

Tumor suppressor genes: new prospects for cancer research.

R E Hollingsworth1, W H Lee.   

Abstract

Cancer is thought to arise from the accumulation of several genetic mutations in a single cell. Until recently, the only tumorigenic mutations that have been studied in detail are those that activate oncogenes. The discovery of tumor suppressor genes, for which inactivating mutations elicit tumorigenesis, has added a new dimension to our understanding of neoplasia. The retinoblastoma susceptibility gene RB is the prototype tumor suppressor gene and has been shown to suppress the transformed phenotype for several different cancers. Additional studies have revealed other tumor suppressor genes that may operate in a variety of tissues through a variety of mechanisms. These mechanisms may regulate the choice between cellular proliferation and differentiation and appear to involve such processes as the initiation of DNA replication, regulation of expression of certain genes, intercellular communication and adhesion, and the transduction of external signals to intracellular effectors. The elucidation of these mechanisms will enhance our understanding of both oncogenesis and the fundamental operations of the cell.

Entities:  

Mesh:

Year:  1991        PMID: 1988694     DOI: 10.1093/jnci/83.2.91

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

Review 1.  Biomarkers and the genetics of early neoplastic lesions.

Authors:  Sudhir Srivastava; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 2.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Domains of E1A that bind p105Rb, p130, and p300 are required to block nerve growth factor-induced neurite growth in PC12 cells.

Authors:  D Kalman; K Whittaker; J M Bishop; P H O'Lague
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

Review 4.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

5.  Alteration in the retinoblastoma gene associated with immortalization of human fibroblasts treated with 60Co gamma rays.

Authors:  A Endo; Y Kano; K Mihara; K Orita; M Namba
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 6.  Free radicals in chemical carcinogenesis.

Authors:  M R Clemens
Journal:  Klin Wochenschr       Date:  1991-12-15

7.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Authors:  N Konishi; Y Hiasa; H Matsuda; M Tao; T Tsuzuki; I Hayashi; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

8.  Wild-type p53 is not a negative regulator of simian virus 40 DNA replication in infected monkey cells.

Authors:  A von der Weth; W Deppert
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Impact of the human genome project on medical practice.

Authors:  B J Rossiter; C T Caskey
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

Review 10.  MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.